These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 8309507)

  • 41. ELISA quantitation of dystrophin for the diagnosis of Duchenne and Becker muscular dystrophies.
    Byers TJ; Neumann PE; Beggs AH; Kunkel LM
    Neurology; 1992 Mar; 42(3 Pt 1):570-6. PubMed ID: 1549217
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Duchenne and Becker muscular dystrophy prevalence in South Africa and molecular findings in 128 persons affected.
    Ballo R; Viljoen D; Beighton P
    S Afr Med J; 1994 Aug; 84(8 Pt 1):494-7. PubMed ID: 7825085
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Dystrophin and DNA diagnosis in a large pediatric muscle clinic.
    Richards S; Iannaccone ST
    J Child Neurol; 1994 Apr; 9(2):162-6. PubMed ID: 8006367
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Gene deletions in Japanese patients with Duchenne and Becker muscular dystrophies: deletion study and carrier detection.
    Asano J; Tomatsu S; Sukegawa K; Ikedo Y; Minami R; Iida M; Nishimura M; Nakagawa M; Ohshiro M; Orii T
    Clin Genet; 1991 Jun; 39(6):419-24. PubMed ID: 1863988
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Amino-terminal deletion of 53% of dystrophin results in an intermediate Duchenne-Becker muscular dystrophy phenotype.
    Takeshima Y; Nishio H; Narita N; Wada H; Ishikawa Y; Ishikawa Y; Minami R; Nakamura H; Matsuo M
    Neurology; 1994 Sep; 44(9):1648-51. PubMed ID: 7936290
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Experience and strategy for the molecular testing of Duchenne muscular dystrophy.
    Prior TW; Bridgeman SJ
    J Mol Diagn; 2005 Aug; 7(3):317-26. PubMed ID: 16049303
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Duchenne and Becker muscular dystrophies: genetics, prenatal diagnosis, and future prospects.
    Bieber FR; Hoffman EP
    Clin Perinatol; 1990 Dec; 17(4):845-65. PubMed ID: 2286031
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Carrier detection in Becker muscular dystrophy using creatine kinase estimation and DNA analysis.
    Kingston HM; Sarfarazi M; Newcombe RG; Willis N; Harper PS
    Clin Genet; 1985 Apr; 27(4):383-91. PubMed ID: 3995787
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Intragenic deletions in 164 boys with Duchenne muscular dystrophy (DMD) studied with dystrophin cDNA.
    Upadhyaya M; Smith RA; Thomas NS; Norman AM; Harper PS
    Clin Genet; 1990 Jun; 37(6):456-62. PubMed ID: 2200624
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Multiplex PCR excludes Duchenne muscular dystrophy in a twin pregnancy.
    Wadelius C; Annéran G; Dahl N; Holmgren G; Gustavson KH
    Clin Genet; 1991 Apr; 39(4):314-6. PubMed ID: 2070552
    [No Abstract]   [Full Text] [Related]  

  • 51. Three years' experience with neonatal screening for Duchenne/Becker muscular dystrophy: gene analysis, gene expression, and phenotype prediction.
    Greenberg CR; Jacobs HK; Halliday W; Wrogemann K
    Am J Med Genet; 1991 Apr; 39(1):68-75. PubMed ID: 1867267
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Duchenne muscular dystrophy.
    Matsuo M
    Southeast Asian J Trop Med Public Health; 1995; 26 Suppl 1():166-71. PubMed ID: 8629099
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Direct carrier detection by in situ suppression hybridization with cosmid clones of the Duchenne/Becker muscular dystrophy locus.
    Ried T; Mahler V; Vogt P; Blonden L; van Ommen GJ; Cremer T; Cremer M
    Hum Genet; 1990 Oct; 85(6):581-6. PubMed ID: 2227948
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Duchenne/Becker muscular dystrophy: from molecular diagnosis to gene therapy.
    Matsuo M
    Brain Dev; 1996; 18(3):167-72. PubMed ID: 8836495
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Pattern of deletions of the dystrophin gene in Mexican Duchenne/Becker muscular dystrophy patients: the use of new designed primers for the analysis of the major deletion "hot spot" region.
    Coral-Vazquez R; Arenas D; Cisneros B; Peñaloza L; Salamanca F; Kofman S; Mercado R; Montañez C
    Am J Med Genet; 1997 Jun; 70(3):240-6. PubMed ID: 9188659
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Carrier and prenatal diagnosis of Duchenne and Becker muscular dystrophy by PCR methods].
    Tsukamoto H; Inui K; Okada S
    Nihon Rinsho; 1993 Sep; 51(9):2428-34. PubMed ID: 8105117
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Quantitative and qualitative alterations of dystrophin are expressed in muscle cell cultures of Xp21 muscular dystrophy patients (Duchenne and Becker type).
    Mongini T; Doriguzzi C; Palmucci L; Chiadò-Piat L
    Eur J Clin Invest; 1996 Apr; 26(4):322-4. PubMed ID: 8732491
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A point mutation in the glycerol kinase gene associated with a deletion in the dystrophin gene in a familial X-linked muscular dystrophy: non-contiguous gene syndrome involving Becker muscular dystrophy and glycerol kinase loci.
    Romero NB; Récan D; Rigal O; Leturcq F; Llense S; Barbot JC; Deburgrave N; Cheval MA; Deniau F; Kaplan JC
    Neuromuscul Disord; 1997 Dec; 7(8):499-504. PubMed ID: 9447607
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Detection of mutation in dystrophin gene in Duchenne muscular dystrophy--multiplex PCR and Southern blot analysis].
    Kawamura J
    Nihon Rinsho; 1997 Dec; 55(12):3126-30. PubMed ID: 9436422
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Dystrophin gene deletion in Chinese Duchenne/Becker muscular dystrophy patients via multiplex DNA amplification.
    Ko TM; Tseng LH; Chiu HC; Hsieh FJ; Lee TY
    J Formos Med Assoc; 1992 Oct; 91(10):951-4. PubMed ID: 1362673
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.